New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback